1st Quarter - Report

THE MCMANUS GROUP for GILEAD SCIENCES, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Support for EPIC Act - H.R. 1492

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1492 (119th)

Health Issues HCR

Issues related to reforming and increasing transparency within the 340B Drug Pricing Program.

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.